A research program leveraging comparative genomics to identify bacterial isolates with plant biocontrol and growth-promotion traits. Combines phylogenetic analysis, genome mining, and functional assays to discover system-specific beneficial microbes for sustainable agriculture applications.
This research program applies comparative genomics and functional characterization to identify plant-associated bacteria with biocontrol and growth-promotion potential. The team has built a collection of more than 500 bacterial isolates from diverse crop production systems and is using phylogenetic and genomic approaches to determine which strains are best suited for specific agricultural applications. The work targets both well-studied genera such as Pseudomonas and Bacillus and less-characterized genera including Sphingobium, Flavobacterium, and Chryseobacterium. By linking genomic features to functional traits like biofilm formation, nutrient mobilization, and antimicrobial activity, the program aims to deliver a curated set of system-adapted bacterial candidates with field-ready potential for sustainable crop protection.
Approach and methodology:
Key findings to date:
Target traits:
The program is at an early-to-mid stage of development. Initial screening and functional characterization of a subset of isolates has been completed, demonstrating proof of concept for biocontrol and growth-promotion activity. Ongoing work focuses on narrowing the isolate set using phylogenetic and comparative genomics analyses, followed by in vitro and in planta validation. The goal is to identify a core set of system-specific isolates ready for field application testing. The research is positioned to advance toward pilot trials and partnerships with agricultural industry stakeholders interested in developing microbial biopesticide and biofertilizer products.
The Ohio State University is a comprehensive public land‑grant research university in Columbus, serving one of the nation’s largest student populations and a broad research enterprise. Industry partners engage through an integrated academic medical center for clinical translation, a campus‑adjacent innovation district for co‑located projects, and a statewide extension network that pilots solutions across Ohio. Corporate engagement provides a single front door for sponsored research, talent pipelines, and streamlined agreements. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, DoD, and NASA. A dedicated technology transfer office and venture support help protect IP, license technologies, and launch startups.